Search research articles
Contact Us
Filters
Showing results (71-80 of 218) with videos related to
Page
of 22
Sort By:
Blood
|
August 17, 2006
Clinical implications of FLT3 mutations in pediatric AML
Soheil Meshinchi, Todd A Alonzo, Derek L Stirewalt, et al.
Cancer
|
February 22, 2017
Prognostic methylation markers for overall survival in cytogenetically normal patients with acute myeloid leukemia treated on SWOG trials
Xiaoyu Qu, Megan Othus, Jerry Davison, et al.
Blood
|
December 13, 2006
Minimally differentiated acute myeloid leukemia (FAB AML-M0) is associated with an adverse outcome in children: a report from the Children's Oncology Group, studies CCG-2891 and CCG-2961
Draga Barbaric, Todd A Alonzo, Robert B Gerbing, et al.
Oncotarget
|
June 2, 2016
Expression and functional characterization of CD33 transcript variants in human acute myeloid leukemia
George S Laszlo, Kimberly H Harrington, Chelsea J Gudgeon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 9, 2015
Gemtuzumab Ozogamicin Reduces Relapse Risk in FLT3/ITD Acute Myeloid Leukemia: A Report from the Children's Oncology Group
Katherine Tarlock, Todd A Alonzo, Robert B Gerbing, et al.
British Journal of Haematology
|
March 26, 2014
Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless of FLT3-ITD status: a report from the Children's Oncology Group
Katherine Tarlock, Todd A Alonzo, Pilar Palomo Moraleda, et al.
British Journal of Haematology
|
November 28, 2008
Cytidine deaminase genotype and toxicity of cytosine arabinoside therapy in children with acute myeloid leukemia
Deepika Bhatla, Robert B Gerbing, Todd A Alonzo, et al.
Research Square
|
March 30, 2023
DRPPM-PATH-SURVEIOR: Plug-and-Play Survival Analysis of Pathway-level Signatures and Immune Components
Alyssa Obermayer, Darwin Chang, Gabrielle Nobles, et al.
Biorxiv : the Preprint Server for Biology
|
November 26, 2025
Acute Myeloid Leukemia Relapse after Bromodomain Inhibitor Treatment or Chemotherapy is Characterized by Myc-Ras Transcriptional Remodeling
Benjamin J Huang, Jeevitha D'Souza, Alexa Rane Batingana, et al.
Nature Communications
|
October 30, 2024
MLL oncoprotein levels influence leukemia lineage identities
Derek H Janssens, Melodie Duran, Dominik J Otto, et al.
Page
of 22
Search research articles
Search
Showing results (71-80 of 218) with videos related to
Sort By:
Page
of 22
Blood
|
August 17, 2006
Clinical implications of FLT3 mutations in pediatric AML
Soheil Meshinchi, Todd A Alonzo, Derek L Stirewalt, et al.
Cancer
|
February 22, 2017
Prognostic methylation markers for overall survival in cytogenetically normal patients with acute myeloid leukemia treated on SWOG trials
Xiaoyu Qu, Megan Othus, Jerry Davison, et al.
Blood
|
December 13, 2006
Minimally differentiated acute myeloid leukemia (FAB AML-M0) is associated with an adverse outcome in children: a report from the Children's Oncology Group, studies CCG-2891 and CCG-2961
Draga Barbaric, Todd A Alonzo, Robert B Gerbing, et al.
Oncotarget
|
June 2, 2016
Expression and functional characterization of CD33 transcript variants in human acute myeloid leukemia
George S Laszlo, Kimberly H Harrington, Chelsea J Gudgeon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 9, 2015
Gemtuzumab Ozogamicin Reduces Relapse Risk in FLT3/ITD Acute Myeloid Leukemia: A Report from the Children's Oncology Group
Katherine Tarlock, Todd A Alonzo, Robert B Gerbing, et al.
British Journal of Haematology
|
March 26, 2014
Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless of FLT3-ITD status: a report from the Children's Oncology Group
Katherine Tarlock, Todd A Alonzo, Pilar Palomo Moraleda, et al.
British Journal of Haematology
|
November 28, 2008
Cytidine deaminase genotype and toxicity of cytosine arabinoside therapy in children with acute myeloid leukemia
Deepika Bhatla, Robert B Gerbing, Todd A Alonzo, et al.
Research Square
|
March 30, 2023
DRPPM-PATH-SURVEIOR: Plug-and-Play Survival Analysis of Pathway-level Signatures and Immune Components
Alyssa Obermayer, Darwin Chang, Gabrielle Nobles, et al.
Biorxiv : the Preprint Server for Biology
|
November 26, 2025
Acute Myeloid Leukemia Relapse after Bromodomain Inhibitor Treatment or Chemotherapy is Characterized by Myc-Ras Transcriptional Remodeling
Benjamin J Huang, Jeevitha D'Souza, Alexa Rane Batingana, et al.
Nature Communications
|
October 30, 2024
MLL oncoprotein levels influence leukemia lineage identities
Derek H Janssens, Melodie Duran, Dominik J Otto, et al.
Page
of 22